As shown in Figure 1, a significant decrease in the cell surface expression of CD33 was detected in monocytes obtained from patients with type 2 diabetes, as compared to those from healthy volunteers (P < 0.05) (Figure 1A and 1B). Here, CD33 is linked to type 2 diabetes mellitus.